Holmusk

New York, NY · Founded 2015 · Privately Held (backing)

Developer of a real-world evidence platform designed to advance behavioral health analytics and improve clinical understanding. Holmusk is based in New York, NY and was founded in 2015. Its last reported valuation was $135 million in Jan 2023. It has raised $114 million across 1 recorded round; the latest was a $30 million early-stage round in Sep 2023.

Last reported valuation
$134.8M
Oct 2026
Priced at
—
Total raised
$113.8M
Last round
Early Stage VC
Sep 2023

Who backs Holmusk?

14 investors
InvestorType
Johnson & Johnson JJDCVenture capital
Optum VenturesVenture capital
OCTAVE Capital (Singapore)Other
Capikris Foundation—
Health Catalyst Capital Management—
Kenneth Ng—
MadDog Ventures—
Northwell Holdings—
Novartis—
Otsuka Pharmaceutical Europe—
+ 4 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Holmusk investors

14 investors are on record for Holmusk, including Johnson & Johnson JJDC, Optum Ventures, OCTAVE Capital (Singapore) and Capikris Foundation. The early-stage round in Sep 2023 drew 1 investor.

Free account
More of Holmusk with a free account
  • ·The complete investor list: 14 names
  • ·Watch Holmusk: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 14 firms already write checks for companies like Holmusk. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View